Skip to main content
中科搏锐(北京)科技有限公司 (CASIBrain) logo

中科搏锐(北京)科技有限公司 (CASIBrain)

Beijing, ChinaSee on the mapFounded 2017

  • Brain-computer interfaces
  • EEG and neural monitoring
  • Series B

CASIBrain is a medical technology company focused on developing, manufacturing, registering, selling, and supporting advanced brain diagnostic and monitoring devices. Its work centers on brain function monitoring, imaging, and evaluation, including anesthesia monitoring, stroke care, and brain-computer interface applications.

Raised
$1.4M
Mar 2026
Series B
Investors
3
Founded
2017
Employees
51–200

reccy insights

Recent highlights

CASIBrain’s most recent listed financing milestone is a Series B dated March 10, 2026, with Sunz Fund named as a lead investor; Sanze Ventures is also associated with that round. Earlier listed milestones are a Series A dated January 30, 2024, with Heyer medical and Beijing Aeonmed, and a seed round dated October 24, 2018, with FutureCap and Future Capital Discovery Fund. The seed round amount is $1,440,092. The company’s product range includes BRS-series anesthesia monitoring devices, the BRS-800 stroke center system, and NEG3200 and NEG4800 systems for brain-computer interface and neurofunctional testing. Its stated areas of work span brain-function monitoring, imaging, and evaluation. The Series B investor is named inconsistently as Sunz Fund and Sanze Ventures in available company information, so both names are retained rather than treated as confirmed duplicates.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

What makes 中科搏锐(北京)科技有限公司 (CASIBrain) distinct

  1. 01Builds on more than 20 years of brain-science research associated with the Institute of Automation, Chinese Academy of Sciences.
  2. 02Works across brain-function monitoring, brain-function imaging, and brain-function evaluation.
  3. 03Combines medical-device research and development with manufacturing, registration, sales, and service.
  4. 04Develops devices for anesthesia monitoring, stroke care, brain-computer interface applications, and neurofunctional testing.

Technology & products4

  • BRS-series anesthesia monitoring devices

    Devices for brain-function monitoring in anesthesia settings.

  • BRS-800

    A stroke center system.

  • NEG3200

    A brain-computer interface and neurofunctional testing system.

Research roots1

Labs and research groups this company came from or works with.

Academic data: Carter Sciences

Recent updates5

  • Jun 16, 2026Award

    脑科学领域国际最高荣誉之一!中科搏锐首席科学家蒋田仔教授获终身成就奖!

    casibrain.com
  • Jun 5, 2026Partnership

    重磅!中科搏锐共建市级重点实验室,引领麻醉疼痛精准医疗新突破!

    casibrain.com
  • Apr 14, 2026Product launch

    中科搏锐携非侵入式脑机接口设备亮相2026CMEF,展台火热引众多专家学者关注!

    casibrain.com

Funding

$1.4M disclosed
  • Series BMar 2026
    Sunz Fund, Sanze Ventures
  • Series AJan 2024
    Heyer medical, Beijing Aeonmed
  • SeedOct 2018
    $1.4MLed by FutureCap, Future Capital Discovery Fund
3 investors

Similar companies

About 中科搏锐(北京)科技有限公司 (CASIBrain)

Products
BRS-series anesthesia monitoring devices, BRS-800, NEG3200, NEG4800
Leadership
Zhang Xin
Focus areas
Brain monitoring, brain-computer interface, anesthesia monitoring, stroke care, neurodiagnostics, medical devices
Headquarters
Beijing, China
Founded
2017
Employees
51–200
Status
Active · private